“We believe the new Category I CPT codes will enable more predictable and consistent reimbursement for Barostim patients and healthcare professionals,” said Kevin Hykes, President and Chief Executive ...

The striking gains in functional capacity and quality of life conferred by baroreflex activation therapy in patients with heart failure, as shown in the pivotal phase 3 clinical trial for this novel ...

SAN DIEGO, CA — In a small trial of patients with heart failure and reduced ejection fraction (HF-REF), those who were implanted with the Barostim neo (CVRx) device, which stimulates baroreceptors in ...

SAN FRANCISCO, CA—In patients with heart failure with reduced ejection fraction (HFrEF) who are not candidates for cardiac resynchronization therapy, baroreflex activation therapy (BAT) provides at ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In certain patients with HF with reduced ejection fraction, baroreflex activation therapy was ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

TUCSON, Ariz. (KVOA) - Carondelet St. Mary's Hospital has successfully completed its first implantation of the Barostim™ Baroreflex Activation Therapy device, marking a significant advancement in the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved revised instructions for use for a neuromodulation device for HF. The instructions now include ...

MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc (CVRX). (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) ...

ALBANY — Doctors at Albany Medial Center have successfully implanted a groundbreaking, recently FDA-approved heart failure device designed to treat patients who haven't had success with other ...

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc (CVRX). (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® ...